ISRG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Intuitive Surgical Inc (ISRG) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The technical indicators show bearish trends, options sentiment is neutral to slightly bearish, and recent analyst ratings reflect a cautious outlook with lowered price targets. Additionally, Congress trading data indicates a cautious stance with recent sale transactions. While the company maintains a strong market position, the lack of significant positive catalysts and the presence of competitive and margin pressures suggest holding off on investment for now.
The technical indicators for ISRG show a bearish trend. The MACD is positive but contracting, RSI is neutral at 39.378, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at $403.432 and resistance at $426.925.
Citadel Advisors increased its stake by 30.3%, showing confidence in the company's long-term growth. ISRG maintains a leading position in the robotic-assisted surgery market due to its extensive experience and customer base.
The stock has dropped 20% over the past year due to declining product margins and tariffs. Analysts have lowered price targets, citing inflation, utilization risks, and competitive pressures. Congress trading data shows recent sales, indicating caution.
Financial data for the latest quarter is unavailable, but analysts have noted challenges in the medtech sector, including slower growth and margin pressures.
Analyst sentiment is mixed but leans cautious. Recent ratings include multiple price target reductions, with some maintaining Buy ratings (e.g., BofA at $515, Goldman Sachs at $558) and others issuing Sell ratings (e.g., Deutsche Bank at $366). Analysts cite inflation, utilization risks, and competitive pressures as key concerns.
